Index RUT
P/E -
EPS (ttm) -1.91
Insider Own 16.88%
Shs Outstand 81.63M
Perf Week 5.19%
Market Cap 1.86B
Forward P/E -
EPS next Y -5.06
Insider Trans -7.32%
Shs Float 67.88M
Perf Month -23.45%
Income -132.53M
PEG -
EPS next Q -1.42
Inst Own 78.36%
Short Float 19.41%
Perf Quarter -14.04%
Sales 377.71M
P/S 4.91
EPS this Y -212.06%
Inst Trans -0.68%
Short Ratio 8.66
Perf Half Y 7.47%
Book/sh 12.02
P/B 1.89
EPS next Y 5.78%
ROA -9.46%
Short Interest 13.17M
Perf Year -24.67%
Cash/sh 14.57
P/C 1.56
EPS next 5Y -3.70%
ROE -15.46%
52W Range 16.95 - 49.50
Perf YTD -16.53%
Dividend Est. -
P/FCF -
EPS past 5Y 5.58%
ROI -11.61%
52W High -54.10%
Beta 1.87
Dividend TTM -
Quick Ratio 5.89
Sales past 5Y 43297.50%
Gross Margin 92.82%
52W Low 34.04%
ATR (14) 1.51
Dividend Ex-Date Feb 04, 2014
Current Ratio 5.89
EPS Y/Y TTM 54.77%
Oper. Margin -46.73%
RSI (14) 34.10
Volatility 5.35% 5.06%
Employees 436
Debt/Eq 0.18
Sales Y/Y TTM 520.01%
Profit Margin -35.09%
Recom 1.93
Target Price 49.54
Option/Short Yes / Yes
LT Debt/Eq 0.16
EPS Q/Q 418.68%
Payout -
Rel Volume 0.69
Prev Close 21.74
Sales Surprise 1593.33%
EPS Surprise 350.29%
Sales Q/Q 1478.04%
Earnings Feb 27 BMO
Avg Volume 1.52M
Price 22.72
SMA20 -8.73%
SMA50 -27.61%
SMA200 -16.32%
Trades
Volume 1,056,890
Change 4.51%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-29-24 Upgrade
JP Morgan
Neutral → Overweight
$38 → $40
Dec-15-23 Downgrade
BofA Securities
Buy → Neutral
$35
Dec-08-23 Downgrade
Jefferies
Buy → Hold
$75 → $30
Oct-20-23 Downgrade
Leerink Partners
Outperform → Market Perform
$75 → $20
Oct-20-23 Downgrade
Cantor Fitzgerald
Overweight → Neutral
Mar-21-23 Initiated
Bernstein
Mkt Perform
$37
Feb-01-23 Initiated
Cantor Fitzgerald
Overweight
$62
Dec-20-22 Upgrade
BMO Capital Markets
Market Perform → Outperform
$61 → $66
Dec-13-22 Initiated
Citigroup
Buy
$62
Jun-17-22 Initiated
BMO Capital Markets
Market Perform
$41
Apr-28-22 Initiated
Credit Suisse
Neutral
$62
Jan-05-22 Initiated
Guggenheim
Buy
$130
Oct-19-21 Initiated
SVB Leerink
Outperform
$117
Sep-24-21 Resumed
Stifel
Buy
$85 → $120
Sep-10-21 Initiated
BofA Securities
Buy
$150
May-11-21 Initiated
Redburn
Buy
May-04-21 Initiated
RBC Capital Mkts
Sector Perform
$85
Mar-01-21 Downgrade
Barclays
Overweight → Equal Weight
$47 → $90
Feb-16-21 Initiated
Wells Fargo
Overweight
$145
Jan-29-21 Downgrade
JP Morgan
Overweight → Neutral
$100
Show Previous Ratings
May-01-24 10:01AM
Mar-28-24 11:30AM
Mar-26-24 06:30AM
Feb-28-24 06:30AM
Feb-27-24 04:01PM
(Investor's Business Daily) +25.89%
02:57PM
Loading…
02:57PM
(Investor's Business Daily)
12:33PM
07:11AM
06:30AM
Feb-20-24 10:00AM
Feb-16-24 02:46PM
(Investor's Business Daily)
Feb-10-24 05:09PM
Feb-07-24 07:35AM
Feb-05-24 06:30AM
Jan-29-24 06:21PM
01:51PM
Loading…
Jan-16-24 01:51PM
09:00AM
Jan-11-24 04:38PM
Jan-08-24 06:30AM
05:52AM
Jan-02-24 06:30AM
Dec-27-23 10:30AM
Dec-15-23 10:22AM
Dec-14-23 06:30AM
Dec-08-23 11:30AM
Nov-30-23 09:55AM
Nov-23-23 11:03AM
09:42AM
Nov-20-23 05:43PM
Nov-18-23 07:15AM
06:49AM
Loading…
06:49AM
Nov-17-23 12:00PM
Nov-14-23 05:50AM
Nov-10-23 09:55AM
Nov-09-23 01:04PM
Nov-08-23 06:30AM
06:30AM
Nov-06-23 08:02AM
(Investor's Business Daily)
Nov-05-23 08:30AM
Nov-01-23 05:40AM
Oct-31-23 07:09PM
04:04PM
(Investor's Business Daily)
10:01AM
10:00AM
06:00AM
05:00AM
Oct-30-23 03:46PM
10:00AM
09:18AM
Oct-27-23 07:15AM
Oct-25-23 06:30AM
05:50AM
01:45AM
Oct-21-23 08:45AM
Oct-20-23 11:43AM
09:37AM
Oct-19-23 09:03AM
08:54AM
08:45AM
Oct-18-23 09:30AM
Oct-05-23 08:45AM
Oct-03-23 06:27AM
Sep-29-23 10:30AM
Sep-27-23 08:30AM
Sep-22-23 05:50AM
Sep-08-23 08:20AM
07:23AM
Sep-07-23 10:00AM
Sep-05-23 06:30AM
Aug-31-23 07:37AM
06:30AM
Aug-26-23 07:50AM
Aug-19-23 05:52AM
Aug-13-23 09:28AM
Aug-11-23 09:35AM
Aug-08-23 07:40AM
06:30AM
Jul-15-23 03:45PM
Jul-09-23 10:23AM
Jun-18-23 05:52AM
Jun-15-23 08:22AM
08:22AM
May-21-23 08:23AM
May-17-23 06:30AM
May-16-23 05:50AM
May-11-23 06:30AM
May-10-23 07:45AM
06:30AM
May-02-23 12:25PM
05:53AM
Apr-28-23 04:51PM
Apr-26-23 02:10PM
Apr-20-23 06:24PM
Apr-18-23 03:47PM
07:00AM
Apr-15-23 08:26AM
Mar-29-23 08:54PM
04:20PM
Mar-27-23 07:30AM
Mar-21-23 06:30AM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Simon Amy Chief Medical Officer Apr 02 '24 Sale 30.54 16,530 504,851 70,060 Apr 03 07:43 PM Evans John M. CEO Apr 01 '24 Sale 32.13 18,102 581,617 1,058,343 Apr 03 07:36 PM Simon Amy Chief Medical Officer Apr 01 '24 Sale 32.13 7,157 229,954 86,590 Apr 03 07:43 PM Burrell Terry-Ann Chief Financial Officer Apr 01 '24 Sale 32.12 5,446 174,926 70,137 Apr 03 07:39 PM Ciaramella Giuseppe President Apr 01 '24 Sale 32.12 4,534 145,632 169,616 Apr 03 07:33 PM Bellon Christine Chief Legal Officer Apr 01 '24 Sale 32.12 3,401 109,240 104,594 Apr 03 07:40 PM Evans John M. CEO Mar 28 '24 Sale 33.86 60,000 2,031,402 998,262 Apr 01 04:10 PM FMR LLC See Remark 1 Feb 14 '24 Sale 30.55 900,000 27,496,912 1,235,511 Feb 15 02:34 PM FMR LLC See Remark 1 Feb 13 '24 Sale 30.76 1,565 48,139 2,771,913 Feb 15 02:34 PM Evans John M. CEO Jan 31 '24 Sale 25.33 60,000 1,519,800 1,058,262 Feb 02 04:05 PM Bellon Christine Chief Legal Officer Jan 03 '24 Sale 26.42 1,907 50,383 80,495 Jan 05 04:30 PM Bellon Christine Chief Legal Officer Nov 20 '23 Option Exercise 7.22 10,000 72,200 92,402 Nov 22 04:05 PM Bellon Christine Chief Legal Officer Nov 20 '23 Sale 30.50 10,000 305,000 82,402 Nov 22 04:05 PM Simon Amy Chief Medical Officer Oct 30 '23 Sale 18.70 3,448 64,478 65,469 Nov 01 04:30 PM Ciaramella Giuseppe President and CSO Oct 20 '23 Option Exercise 0.67 90,900 60,903 139,150 Oct 24 04:05 PM Bellon Christine Chief Legal Officer Oct 02 '23 Sale 22.85 388 8,866 82,402 Oct 04 04:30 PM Ciaramella Giuseppe President and CSO Jul 24 '23 Option Exercise 7.22 1,206 8,707 49,456 Jul 25 06:36 PM Ciaramella Giuseppe President and CSO Jul 24 '23 Sale 32.01 1,206 38,604 48,250 Jul 25 06:36 PM Ciaramella Giuseppe President and CSO Jul 21 '23 Option Exercise 7.22 91,284 659,070 203,574 Jul 25 06:36 PM Ciaramella Giuseppe President and CSO Jul 21 '23 Sale 32.06 155,324 4,979,687 48,250 Jul 25 06:36 PM Simon Amy Chief Medical Officer Jul 10 '23 Sale 30.48 391 11,918 68,917 Aug 09 04:08 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite